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Abstract
Alternative splicing (AS) is a closely regulated process that allows a single gene to encode 
multiple protein isoforms, thereby contributing to the diversity of the proteome. Dysregulation of 
the splicing process has been found to be associated with many inherited diseases. However, in 
amongst the pathogenic AS events there are numerous “passenger” events whose inclusion or 
exclusion does not lead to significant changes with respect to protein function. In this study, we 
evaluate the secondary and tertiary structural features of proteins associated with disease-causing 
and neutral AS events, and show that several structural features are strongly associated with the 
pathological impact of exon inclusion. We further develop a machine learning-based 
computational model, ExonImpact, for prioritizing and evaluating the functional consequences of 
hitherto uncharacterized AS events. We evaluated our model using several strategies including 
cross-validation, and data from the Gene-Tissue Expression (GTEx) and ClinVar databases. 
ExonImpact is freely available at http://watson.compbio.iupui.edu/ExonImpact
Keywords
alternative splicing; exon impaction; disease; machine learning
*Corresponding authors WF: fengweixing@hrbeu.edu.cn, YL: yunliu@iu.edu. 
Competing financial interests
The authors are unaware of any competing interests.
Author contributions
YL and ML designed the work program and drafted the manuscript. ML and XZ wrote the code and implemented the analysis. MM 
and DNC provided training data from the HGMD database. YY and YZ performed the protein structure analysis. MM, DNC, YW and 
YZ participated in the writing of the manuscript and the interpretation of the results.
HHS Public Access
Author manuscript
Hum Mutat. Author manuscript; available in PMC 2018 January 01.
Published in final edited form as:
Hum Mutat. 2017 January ; 38(1): 16–24. doi:10.1002/humu.23111.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Introduction
Alternative splicing is a tightly regulated process by which exons in the pre-mRNA 
transcripts are differentially joined or skipped, thereby allowing a single gene to encode 
multiple protein isoforms. As an important level of gene regulation that greatly contributes 
to proteome diversity, alternative splicing is a widespread phenomenon in eukaryotic cells, 
which plays key roles in a variety of biological processes, including cell division, cell fate 
decisions, tissue maturation and cellular responses to the changes of extracellular 
environment, such as responses to stress (Chen, et al., 2014). Importantly, many studies have 
suggested that dysregulation of the alternative splicing process is associated with a wide 
variety of human genetic diseases (Faustino and Cooper, 2003). Therefore, investigating the 
functional effects of individual alternative splicing events is crucial to understanding the 
complexity of biological systems and the molecular mechanisms of human disease.
Recent advances in the development and implementation of high-throughput sequencing 
technology have enabled the profiling of pre-mRNA splicing patterns on a genome-wide 
scale. Many alternative splicing events can be identified from RNA-seq data using existing 
bioinformatics tools such as Mix-of-Isoforms (MISO, Katz, et al., 2010), Multivariate 
Analysis of Transcript Splicing (rMATS, Shen, et al., 2014), SpliceTrap (Wu, et al., 2011), 
and ASprofile (Florea, et al., 2013). Despite these advances, very few tools are actually 
available for evaluating the functional impact of individual alternative splicing events on 
protein function. Indeed, several studies suggest that only a subset of alternative splicing 
events have an influence on protein function (Lu, et al., 2009). In addition, our previous 
work on non-frameshifting INDELs (insertions /deletions) showed that the addition or 
omission of a limited number of amino acid residues does not guarantee a functional change, 
unless the residues occur within key structural elements of the protein (Zhao, et al., 2013). 
Therefore, a systematic strategy to prioritize functional alternative splicing events will be 
essential for biologists to identify important candidates for further mechanistic investigation.
Several studies have attempted to select the most influential events based on the genomic 
and protein structure features in the vicinity of the alternatively spliced exons. For instance, 
Lu et al. (Lu, et al., 2009) designed a prediction method by combining multi-genome 
alignment data with RNA selection pressure calculations, which were based on the number 
of synonymous variants within the alternatively spliced exons and flanking intronic regions. 
The reliability of this method is predicated upon the assumption that such regions are 
enriched with binding sites for splicing regulatory factors, and should therefore be depleted 
of variants responsible for functionally important events. Other studies have evaluated the 
potential impact of individual alternatively spliced exons on protein function by examining 
their overlap with known protein functional domains, post-translational modification sites, 
and binding domains that facilitate protein-protein interactions. It has been observed that the 
proteins containing tissue-specific alternative exons tend to have a greater number of 
interactions in the protein-protein interaction (PPI) networks, suggesting their widespread 
role in controlling the tissue-specific dynamics of the protein interactions (Ellis, et al., 
2012) .
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Prompted by these studies, we systematically evaluated the protein structural features that 
are related to the exons whose splicing outcomes are associated with human inherited 
disease. By comparing the exons containing disease-causing variants documented in the 
Human Gene Mutation Database (Stenson, et al., 2014) and the exons containing putatively 
non-harmful insertions/deletions in the 1000 Genomes Database (Consortium, 2012), we 
confirmed that several features relating to protein structure are strongly associated with the 
disease-relevance or otherwise of the exon inclusion status. We further developed an 
algorithm, ExonImpact, to predict the disease relevance of the alternatively spliced exons 
that have not been previously investigated. The model was further evaluated by a subset of 
an independent test set from our own data set, splicing patterns derived from the GTEx 
(Genotype-Tissue Expression) database (GTEx Consortium, 2013) and the ClinVar 
(Landrum, et al., 2014) database, which document both the benign and pathogenic mutations 
from clinical testing, literature curation and population studies. Our results suggest that 
ExonImpact can reliably identify disease-causing events, derived from various genome-wide 
studies, located within hundreds of alternatively spliced exons. The schematic of the overall 
study is illustrated in Figure 1.
Materials and Methods
Disease-causing and neutral alternatively spliced exons
In order to systematically evaluate the impact of protein structure features that are associated 
with pathogenic and neutral AS events, we first constructed a database that contains a group 
of exons whose splicing outcomes have strong implications for various diseases (positive 
dataset), and others that are considered to be neutral (negative dataset). For a positive 
training set, we extracted 4,667 exons containing 7,639 deleterious single nucleotide variants 
(SNVs) documented in the Human Gene Mutation Database (HGMD) that are responsible 
for causing human inherited disease by disrupting splicing regulation (Stenson, et al., 2014). 
The SNV-induced splicing abnormality associated with these exonic events has been 
previously demonstrated to cause documented phenotypic consequences. The negative 
training set, i.e. the alternatively spliced events that are presumed to be functionally neutral, 
were derived from the 1000 Genomes database, in which genotyped individuals do not 
exhibit any apparent clinical phenotypes. Since genotyping information from the 1000 
Genomes Project does not provide the profiling of exonic splicing patterns, we turned our 
attention to the small exonic insertions/deletions (exo-INDELs, the length of the INDELs is 
less than 21 nts), whose outcome at the protein level is the inclusion or exclusion of a stretch 
of amino acid residues. This consequence is similar to the results of alternative splicing. 
Although small exo-INDELs usually only represent a proportion of the entire exon, we 
constructed our negative training set by compiling all the INDEL-containing exons, 
assuming the fitness of the individuals is less sensitive to the status of the exons being either 
included or excluded from the protein product. It should be noted that this strategy might 
result in the inappropriate inclusion of deleterious events in the negative training data set, 
especially when the functional domains of the protein are encoded by part of the exon that 
lies outside of the exo-INDEL regions. Our overall training dataset contained 4,211 and 
2,664 exons in the positive and negative training groups, respectively.
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ClinVar test dataset
An independent test dataset was collated from the NCBI ClinVar database. The test data set 
included 1,032 and 11 exons containing pathogenic and benign variants in the splicing sites 
(see Supp. Table S2). In addition, the ClinVar database also documented 1,652 and 36 exons 
containing pathogenic and benign exo-INDELs, respectively.
SPANR prediction
Splicing-based Analysis of Variants (SPANR, Xiong, et al., 2015) was used to evaluate the 
roles of the 1,000 Genomes Project variants in disrupting splicing regulation. We used the 
maximum mutation-induced change in PSI (percent-spliced-in) across 16 tissues that is 
reported by SPANR by default.
MISO prediction
In order to examine the inclusion ratios (ψ, percent-spliced-in) of the exons with high FIS 
(Functional Impact Scores), we ran MISO (mixture of isoforms) analysis on RNA-seq data 
from 310 brain samples across 11 brain regions, as documented in the GTEx (Genotype-
Tissue Expression project, (GTEx Consortium, 2013), and downloaded from dbGaP. 
Without losing generalizability, we only analyzed the 42,485 skipped exons (SE) that were 
documented in the MISO annotation. For each event, MISO provides maximum likelihood 
estimation on the ψ for each sample, as well as its 95% confidence interval (CI). A wide CI 
indicates less accurate prediction. We therefore removed all the events with no more than 10 
samples containing CI≤0.1. After this filtering step, 1,909 events remained. After removing 
the first and last exons, and the exons in the non-coding genes, ExonImpact calculated FIS 
scores for a total of 1,852 events. Default parameters were used for MISO calculation.
Features
Disorder, ASA, and secondary structure predictions—For all the exon regions to 
be evaluated, a series of SPINE algorithms were used to derive its structure-related features. 
SPINE-D (Zhang, et al., 2012) was used to predict the disorder probability, and SPINE-X 
(Faraggi, et al., 2012) was used to predict soluble accessible surface areas (ASA) and protein 
secondary structures (helix, sheet or coil). Default parameters were used for both algorithms.
Pfam domains—In order to quantify the level of overlap between the alternatively spliced 
exons and known protein family domains, Pfam (version 28.0) was used to predict the 
putative domains derived from amino acid sequences. We used two measurements as input 
features: the proportion of the exons that overlap with predicted protein family domains, and 
the proportion of predicted protein family domain that overlap with the candidate exon. If 
more than one domain was overlapped, we used the maximum percentage across all the 
domains.
Post-translational Modification (PTM)—PTM features were derived from the dbPTM 
database (Huang, et al., 2016) and we only considered the experimentally-validated PTMs. 
The PTM feature was defined as the number of documented PTM sites in the exon, 
normalized by the exon length.
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Machine learning algorithm—The RandomForest algorithm (Liaw and Wiener, 2002) 
was used for model training and prediction. Performance evaluation was performed using 
10-fold cross-validation and bootstrapping (100 trees, mtry = 12). We found the performance 
of the RandomForest model was not sensitive to the selection of parameters. In addition, an 
independent test data set that had not been used in training the model was used to evaluate 
model performance.
Results
Disease-causing AS events have distinct protein structure features
In order to examine what differentiates the pathogenic and neutral AS events, we 
systematically evaluated dozens of protein structure features that are potentially associated 
with alternatively spliced exons. Features were clustered into five categories, each with 
slightly different measurements (Supp. Table S1). The five categories included solvent 
accessible surface area (ASA), protein secondary structure, probability of intrinsic 
disordered region (disorder score), relationship with known protein family domains, and the 
presence of known post-translational modification (PTM). In addition, the evolutionary 
conservation scores and the length of the alternatively spliced region were also included.
Disease-causing AS events tend to locate in structured protein regions—
Intrinsically disordered protein (IDP) regions are stretches of amino acid residues that lack a 
fixed or ordered three-dimensional structure. Compared to structured proteins, IDPs tend to 
have distinct properties in terms of function, structure, sequence, interactions, evolution and 
regulation. The disorder measurement is calculated using SPINE-D (Zhang, et al., 2012), an 
algorithm that we previously developed to predict disorder probability based on a protein’s 
amino acid sequence. For each amino acid residue, SPINE-D reports a disorder score 
ranging from 0 to 1, where 0 and 1 indicate that the residue in question locates fully within 
structured and disordered regions, respectively. We define 12 features to characterize the 
disorder status of the AS exon (Supp. Table S1); one example of the 12 features can be 
found in Supp. Figure S1. Each feature is evaluated based on its power to discriminate the 
AS events in the positive (disease-causing) and negative (neutral) training sets. All the 12 
disorder-related features showed different distributions between the positive and negative 
training sets (one-sided Wilcoxon rank-sum test) with most features exhibiting p-values < 
1×10−16 (Figure 2C). The probability density function (PDF) and cumulative distribution 
function (CDF) of one representative disorder feature, the maximum disorder score of all the 
amino acids, are shown in Figures 2A and 2B. As with our earlier observation on small exo-
INDELs (Zhao, et al., 2013) , pathogenic AS events exhibited significantly lower disorder 
scores, suggesting that they tend to be located within structured protein regions.
Disease-causing AS events tend to be buried inside core regions of protein 
structures—Solvent accessible surface area (ASA) is a measurement of the surface area of 
a protein that is accessible to a solvent. A smaller ASA value usually indicates that an amino 
acid residue is buried within the core regions of the protein structure, whereas a larger ASA 
value suggests that it is exposed on the protein surface. For each amino acid residue, we 
calculated its ASA value using SPINE-X (Faraggi, et al., 2012). For each exon, three ASA-
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related measures, average, minimum and maximum ASA values across all residues in the 
exon, were used to assess the differences between disease-causing and neutral AS events. As 
with protein disorder measurements, all three features showed statistically significant 
differences in terms of their distributions between the two groups of exons (one-sided 
Wilcoxon rank-sum test, p-value<1×10−16). Figure 2B clearly demonstrates that the 
pathogenic AS events have lower average ASA values, and therefore tend to be buried inside 
the core protein structures.
Protein secondary structures—In addition to protein tertiary structure, secondary 
structures serve to define the distinct characteristic local structural conformation of the 
proteins, and hence also play important roles in protein function. In order to evaluate how 
the secondary structure states of the AS exons affect their disease-causing potential, we used 
SPINE-X to predict the three predominating states, helix, sheet and random coil, for all the 
disease-causing and neutral AS events documented in our training data set. As with protein 
disorder and ASA measurement, for each amino acid residue in the exon, three scores were 
calculated corresponding to the probabilities of each of the three states (helix/sheet/coil) 
being adopted. For each AS event, 12 features were derived from the three probability scores 
for every amino acid residue encoded by the exon, including the maximum, average and 
minimum probabilities of all the residues associated with helix, sheet or coil states. In 
addition, the maximum, average and minimum probabilities of all the residues associated 
with the most probable secondary structure state are also included. We observed strong 
relationships between an exon’s secondary structure state and its disease association. All 12 
secondary structure-derived features exhibited different distributions between disease-
causing and neutral AS events, with significant p-values (two-sided Wilcoxon rank-sum test, 
Figure 2C). This suggests that secondary structures alone provide insufficiently strong 
discriminant power to predict the disease relevance of specific exons.
We further examined whether protein secondary structures might provide additional 
information in separating pathogenic and neutral AS events in combination with tertiary 
structural features. We found that random coil structures on the protein surface (with high 
ASA scores) are strongly associated with deleterious AS events (Figure 3A). Similar results 
were observed with the intrinsic disordered regions. Since random coil structures are often 
present at key protein-protein and protein-DNA/RNA interaction domains (Ghoorah, et al., 
2015), disrupting such regions can lead to detrimental phenotypic consequences. Taking the 
SPAST (spastin) gene as an example (Figure 3B), in the HGMD database, the mutation at 
chr2:32339706 locus is listed as altering the regulation of splicing of the fifth exon 
(NM_014946:227:290), and leads to a disease called spastic paraplegia (Ivanova et al., 
2006) . According to UniProtKB (Uniprot ID: Q9UBP0,NM_014946), this region of the 
protein encodes a random coil structure, and serves as an interaction site with microtubules. 
Such an observation strongly suggests that protein secondary structures complement the 
tertiary structure features, and should play a key role in prioritizing functional AS events.
Disease-causing AS events are enriched for known protein family domains—
Aberrant alternatively spliced exons can disrupt protein function by breaking up protein 
family domains. For each AS event in the training set, we determined whether the exon 
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overlapped with a putative protein family domain, predicted by searching its sequence 
against the profiles of hidden Markov models characterizing the documented protein 
families in the Pfam library (Finn, et al., 2016). For each exon, we calculated the proportion 
of predicted domains covered by the AS exon, and the proportion of the AS exon that 
overlapped with the predicted domains. Both features showed different distributions between 
the positive and negative datasets (Supp. Figure S2), with disease-causing events displaying 
enriched overlap with predicted protein family domains (one-sided Wilcoxon rank-sum test 
p-value<2.2×10−16).
Disease-causing AS exons exhibit different PTM density comparing to neutral 
events—Post-translational modifications (PTMs) are chemical changes on specific amino 
acid residues, which provide key molecular mechanisms for both diversifying and regulating 
the functions of proteins. Splicing variants of the exons containing the key PTM sites have 
the potential to influence both the function and signaling of the protein. We postulated that 
pathogenic AS exons would tend to contain a higher density of PTM sites since they may be 
enriched in signaling elements. For each AS exon, we define PTM density as the proportion 
of the amino acid residues that have documented an experimentally validated PTM site. 
Perhaps surprisingly, we observed a higher PTM density among the neutral AS events, the 
opposite of what we had expected. This is likely to be due to the fact that disease-causing 
events tend to be buried within the protein structures (with lower ASA values), whereas 
PTM sites tend to be located on the surface of the protein structure. We therefore performed 
logistic regression analysis for modeling the group of AS exons (disease-causing or neutral) 
by using both the average ASA and the PTM density as independent variables. The PTM 
density received a positive coefficient (beta=0.037) with a p-value=0.02. This suggests that 
higher PTM density is associated with disease-causing potential when correcting for the 
effect of the length of the exon, i.e. among the surface-located residues, those exons 
containing known PTM sites are more likely to be disease-associated than non-PTM sites. 
Consistent with earlier results (Figure 2A), we observed a negative coefficient (beta=−0.078, 
p-value<1×10−16) for the average ASA, indicating that disease-causing events tend to have 
smaller ASA values.
Relationships among various structural features
Many of the features being evaluated are related to the tertiary structures of the proteins, and 
are therefore not independent. In order to examine the correlation structures of all the 
features, we performed principal component analysis (PCA) on the training set containing 
both deleterious and neutral AS events. As shown in the biplot (Figure 4), the first two 
principal components account for 47.6% of the total variations. The first principal 
component clearly aligns with most features derived from protein tertiary structures, 
including disorder scores, ASA scores and protein family domains. Protein secondary 
structure-related features, however, contribute more to the second principal component. 
Clearly, the first principal component makes the largest contribution toward separating the 
two groups of events, whereas minimum random coil score and maximum ASA scores are 
the two features that point to the small group of disease-causing events in the unstructured 
regions.
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Construction of a machine-learning model for prioritizing AS events in relation to their 
disease relevance
We built a predictive model, ExonImpact, for prioritizing disease-causing AS events using 
the Random Forest algorithm, which comprises a collection of decision trees that vote on the 
output (deleterious or neutral). Two thirds of the events (1,776 disease-causing and 1,776 
neutral events), randomly selected from the gold-standard data set, were used to train the 
model, whereas the other one third (882 disease-causing and 882 neutral events) were used 
for model validation. Based on the prediction results from the validation data set, 
ExonImpact yielded 0.83 for the AUC (Area Under the Curve) of the ROC (Receiver 
Operating Characteristic). Similar performance was achieved when all the experiments were 
replicated 100 times with random sampling from the gold-standard data set (Supp. Figure 
S3A and S3B). To test if the resultant AUC could have been due to homologous genes in the 
training set, we used the HGNC gene family (Gray, et al., 2015) to cluster the disease-
causing and neutral exons respectively, retaining one gene in each family. This reduced the 
total number of positive and negative exons to 1,914 and 651 exons, respectively. Ten-fold 
cross-validation based on this reduced training data set yielded an AUC of 0.835, which 
suggests that homologous genes did not artificially boost the model performance.
For each AS exon, the Random Forest model outputs a functional impact score (FIS) 
ranging from 0 to 1 that is equivalent to the posterior probability of the event falling into the 
disease-causing category. In order to select the cutoff FIS score with the desired statistical 
stringency, we calculated TPR (True Positive Rate), FPR (False Positive Rate), F1 score, and 
MCC (Matthews Correlation Coefficient) corresponding to different cutoffs (Figure 5C). 
When controlling the FPR at 0.1, the cutoff score from Random Forest model was 0.82. At 
this FIS cutoff score, the corresponding True Positive Rate (TPR, or sensitivity), F1 score, 
and Matthews Correlation Coefficient (MCC) were 0.502, 0.63 and 0.44, respectively. The 
FIS cutoff score for FPR at 0.05 was 0.91 with TPR=0.25, F1=0.32, and MCC=0.365.
Exons containing 1,000 Genomes variants that alter splicing regulation tend to have 
smaller functional impact scores
We evaluated all the common coding variants in the 1,000 Genomes Project in relation to 
their potential to disrupt splicing regulation using SPANR (Splicing-based Analysis of 
Variants, (Xiong, et al., 2015) , a bioinformatics tool that provides a score (ΔΨ) which 
characterizes the variant-induced changes in the proportion of transcripts with the exon 
spliced in. We hypothesized that the variants with the highest impact on exon inclusion 
(higher ΔΨ value) should reside within the exons with lowest functional impact scores 
(FIS), since the genotyped individuals of the 1,000 Genomes Project did not exhibit any 
obvious clinical phenotypes. We focused our analysis on the common coding variants with 
MAF (Minor Allele Frequency) ⩾ 5% that reside in the ±20bp exon region around the splice 
site. As shown in Figure 5B, we observed sizable differences in the FIS scores for the exons 
containing variants with weak (|ΔΨ|<10%), intermediate (10%⩽|ΔΨ|<20%) and strong ((|
ΔΨ|⩾20%) impact on splicing regulation. For the exons containing variants with weak 
regulation impact, 16.7% of the exons have FIS scores larger than 0.91 (cutoff for 
FPR⩽0.05). As expected, the proportion decreased to 8.3% and 5.4% for the exons 
harboring variants with intermediate and strong impact on splicing regulation, respectively. 
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The FIS scores of the events with strongly ((|ΔΨ|⩾20%) and weakly (|ΔΨ|<10%) impacting 
variants showed significant differences with p-value=0.009 (two-sided Wilcoxon rank-sum 
test).
Independent test with ClinVar database
We further tested the effectiveness of our algorithms on an independent data set documented 
in the ClinVar database (Landrum, et al., 2014), a public archive of reports of relationship 
among medically important variants and phenotypes. Among the 1,032 exons containing 
deleterious splicing-altering variants, 498 (48%) were predicted to be pathogenic when using 
the FIS=0.91 cutoff (FPR ⩾ 0.05). We further examined the exons that contain benign 
variants at splicing junction sites. These variants are very likely to change splicing outcome, 
but did not lead to pathogenic phenotypes. Among the 11 exons that fitted into this category, 
only 2 (18%) were predicted to be pathogenic (FIS ⩾ 0.91, FPR ⩽ 0.05). The FIS scores for 
the pathogenic events are significantly higher than those for benign events (one-sided 
Wilcoxon rank-sum test p-value<0.01).
We further examined the differences between exons containing pathogenic and neutral 
INDELs that are documented in ClinVar. The current ClinVar database contains 308 and 
5,554 benign and pathogenic INDELs, located in 36 and 1,652 exons respectively. In order 
to avoid an evaluation bias due to the overlapping entries in the HGMD and ClinVar 
databases, we re-trained our model using the HGMD entries that were not included in the 
ClinVar database, and tested the prediction results on the pathogenic events derived from the 
ClinVar database. We found that the new model’s TPR was similar to the cross-validation 
results using HGMD only. When using cutoff FIS=0.82, which corresponds to a 10% False 
Positive Rate (FPR), 662 out of 1,652 pathogenic events (40.1%) were predicted to be 
functionally important. Similarly, the FIS scores on 478 events (28.9%) were larger than 
0.91, which is equivalent to a 5% FPR. This proportion contrasts with the exons containing 
benign INDELs. None of the 36 benign exons are predicted to be functionally important 
when selecting the FIS cutoffs based on a 10% FPR. The overall distribution of the FIS 
scores for pathogenic and benign exons also showed significant differences (Supp. Figure 
S4, two-sided Wilcoxon rank-sum test p-value<1.8×10−14), with the scores for the benign 
group skewing to the left (lower FIS scores), whereas the pathogenic ones skew to the right 
(higher FIS scores).
Exons with strong FIS scores have higher inclusion ratios in human brain
In order to further evaluate the biological relevance of the predicted FIS scores, we 
examined whether there were differences in the exon inclusion ratios for the exons with high 
and low FIS scores (NB. this analysis does not use the mutation information). We 
hypothesized that higher inclusion ratios would be observed for the exons with high FIS 
scores since their functions are more likely to be essential. Using the MISO (Mixture of 
Isoforms) algorithm, we evaluated the inclusion ratios (percent-spliced-in, ψ) of 42,485 
previously documented skipped exon (SE) events on 310 RNA-seq samples from 11 brain 
regions of 44 individuals, collected in the Genotype-Tissue Expression (GTEx) database. 
Among the 42,485 SE events, measurements of the ψ values on 1,909 events were reliably 
identified (the confidence interval for ψ value, CI⩽0.1) in no fewer than 10 RNA-seq 
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samples. Among these events, 1,852 events located to within the middle exons of protein 
coding genes. FIS scores for these events were calculated using the ExonImpact model. All 
events were categorized into three groups based on their FIS scores, FIS<0.82 (FPR>0.05) 
0.82⩽FIS<0.91 (0.01<FPR⩽0.05), and FIS⩾0.91 (FPR⩽0.01). We found that in the 
FIS⩾0.91 group, 93.8% of events had a very high inclusion ratio (ψ>0.8), whereas this 
percentage dropped to 91.3% in the 0.82⩽FIS<0.91 group, and to 71% in the FIS<0.82 
group (two-sided Wilcoxon rank-sum test between FIS<0.82 and FIS⩾0.91, p-value =0.004, 
Figure 6). This observation strongly supports our hypothesis that the events with higher 
functional impact scores are required by the individual, and therefore have much higher 
inclusion ratios.
Discussion
As an essential molecular mechanism that significantly contributes to proteome diversity, 
alternative pre-mRNA splicing selectively includes or excludes certain protein coding 
elements, thereby allowing the coding of proteins with distinct functionalities. With the 
increasing popularity of high-throughput sequencing technology in transcriptome-wide 
profiling, our ability to identify splicing variants has been greatly enhanced. Usually, 
hundreds or even thousands of alternatively spliced events can be identified when comparing 
different tissues (Florea, et al., 2013), and dozens to hundreds of events will be discovered 
when comparing the same tissue at different developmental stages (Wang, et al., 2014). 
Despite the large number of alternatively spliced exons with different cellular status, not all 
the changes in the exon inclusion ratio have obvious biological consequences. The variations 
in many of the splicing events simply reflect the differences in cellular conditions, and will 
not affect the functions of the proteins produced. Our earlier study on coding exonic 
INDELs (Folkman, et al., 2015; Zhao, et al., 2013) also indicates that the addition or 
deletion of a short stretch of amino acid sequence does not guarantee pathological 
consequences.
In this study, we systematically examined the protein structure features that distinguish 
pathogenic from non-pathogenic AS events. Our results suggest that most protein structure-
related features, including disorder score, ASA values, and Pfam prediction, differ 
significantly between the two groups of events. In addition, protein secondary structures, 
random coil in particular, also offer additional predictive power when the tertiary structure 
features fail to recognize the differences. The positions of the pathogenic events in the 
protein may reflect the locations of the interaction domains with other molecular 
components, such as DNA, RNA or other proteins.
The proposed ExonImpact model uses features describing the secondary and tertiary 
structures of the candidate splicing events. Although such features can be acquired from 
various biochemical assays, such as X-ray crystallography or nuclear magnetic resonance 
technologies, they are only available for a small proportion of protein regions. In order to 
broaden the utility of our algorithm, we adopted prediction-based methods for deriving the 
protein structure-related features directly from a series of neural-network-based SPINE 
techniques that make amino acid sequence-based predictions for protein secondary 
structures, ASA (Faraggi, et al., 2012), and disorder probability (Zhang, et al., 2012) . Such 
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a strategy was used in our early work for prioritizing the functions of exo-INDELs (Zhao, et 
al., 2013) (Folkman, et al., 2015). This allows us to prioritize the events whose 
experimentally determined structures are not available.
For machine-learning-based prediction algorithms, the selection of training data set is 
critical, and may have a major influence on prediction accuracy. In this study, the positive 
(deleterious) and negative (neutral) events were selected from two resources. The positive 
events were selected from the exons containing disease-causing variants that have been 
determined to disrupt splicing outcome of the exon, as documented in the Human Gene 
Mutation Database. Selection of “negative” training sets (neutral exons) was more 
challenging, since there is no existing database documenting such events. We therefore 
selected exons containing micro-INDELs from the 1000 Genomes database as our putatively 
neutral data set. Since these INDELs were identified in apparently healthy individuals, the 
addition or removal of a few amino acids in these exons should be less likely disease 
causing. Since INDELs are in general shorter than the exons, we extended the “neutral” 
region to the entire exon. We consider that this exon is located within a functionally 
dispensable region. It is conceivable that the sequences outside of the INDEL regions (non-
frameshift INDELs in particular) in these exons are functionally important. This will 
generate false negatives in our training set, thereby reducing the accuracy of the model’s 
prediction. This implies that our negative training set may contain data that should be part of 
the positive group, and if this is so, it may reduce the discriminant capacity of some key 
features between the two groups. Such inaccuracy, however, will potentially decrease the 
discriminant powers of the features, thereby making the prediction more conservative. 
Another potential source of bias is that we did not consider the potential variable penetrance 
of the genetic mutations (in HGMD and ClinVar) on splicing outcome of the protein. Such 
data are not available in the existing databases, and full penetrance was assumed during the 
model training. In the model validation stage, however, the effects of individual variants on 
splicing outcome is predicted using SPANR, and has been considered.
It should be noted that most of the positive training dataset from the HGMD database are 
exon-skipping events. However, the model trained using these exons can be used to prioritize 
other types of splicing events, including alternative 5’- and 3’- splicing sites, mutually 
exclusive exons, and intron retentions. This is because ExonImpact mainly uses the protein 
level features of the alternatively spliced regions, but does not consider the genomic 
mechanisms that lead to the splicing variants. We also want to point out that ExonImpact 
prioritizes the alternative splicing events based on their possible influence on protein 
structure and function, but cannot be used to directly infer the phenotypical consequence of 
the changes. Other bioinformatics tools for gene function annotation and prediction should 
be jointly used for that purpose.
In order to increase the usability of our model, we provided two means for using 
ExonImpact, both through a web server (http://watson.compbio.iupui.edu/ExonImpact/), and 
a downloadable version (1.0, https://github.com/regSNPs/ExonImpact). Our tool did not 
depend on the mutations so only exon regions are needed. Our tool accepts both the BED 
format defining the alternatively spliced exon region and MISO event formats (examples can 
be found on the website).
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
The workflow of the study, which contains four major components: data collection, feature 
extraction, model training and model evaluation.
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Figure 2. 
Feature evaluation. (A) Probability density of each feature in pathogenic and neutral groups, 
respectively. (B) Probability cumulative density of each feature in HGMD and neutral 
groups, respectively. (C) Scatter plot of Wilcoxon rank-sum test’s p-values for each category 
of features. X-axis shows the −log10 (p-value).
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Figure 3. 
(A) Scatter plot between the average ASA score and the minimum probability of random 
coil. (B) An example (NM_014946) demonstrating the relationship between protein 
secondary and tertiary structures.
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Figure 4. 
PCA biplot of all features. Red and green dots represent pathogenic and neutral events, 
respectively. Each arrow line demonstrates one feature, and the color of the line indicates its 
category.
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Figure 5. 
(A) ROC curve on an independent test data set. (B) Employing the 1,000 Genomes Project 
data set, the percentage of predicted high impact events (FIS ⩾ 0.91) among the events with 
weak, intermediate and strong variants that disrupt splicing are shown. (C) Relationship 
between True Positive Rate, False Positive Rate, F1 Score, MCC with cutoff, y=0.1 and 
x=0.82 is plotted to show the corresponding cutoff for the False Positive Rate = 0.1.
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Figure 6. 
Proportion (%) of events with different levels of inclusion ratio in human brains that have 
low, intermediate and high FIS scores.
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